Cytosolic Phospholipase A2 in Infiltrating Monocyte Derived Macrophages Does Not Impair Recovery After Spinal Cord Injury in Female Mice

Overview

Journal Sci Rep

Specialty Science

Date 2025 Jan 2

PMID 39747330

Authors

Ethan P Glaser

Timothy J Kopper

William M Bailey

Hassan K Kashif

Reena Kumari

Andrew N Stewart

John C Gensel

Affiliations

Soon will be listed here.

Abstract

Spinal cord injury (SCI) leads to permanent motor and sensory loss that is exacerbated by intraspinal inflammation and persists months to years after injury. After SCI, monocyte-derived macrophages (MDMs) infiltrate the lesion to aid in myelin-rich debris clearance. During debris clearance, MDMs adopt a proinflammatory phenotype that exacerbates neurodegeneration and hinders recovery. The underlying cause of the lipid-mediated MDM phenotype shift is unclear. Our previous work suggests that cytosolic phospholipase A2 (cPLA2) plays a role in the proinflammatory potentiating effect of myelin on macrophages in vitro. Cytosolic phospholipase A2 (cPLA2) frees arachidonic acid from phospholipids, generating eicosanoids that play an important role in inflammation, immunity, and host defense. cPLA2 is expressed in macrophages along with multiple other cell types after SCI, and cPLA2 inhibition has been reported to both reduce and exacerbate secondary injury pathology recovery. The role of cPLA2 in MDMs after SCI is not fully understood. We hypothesize that cPLA2 activation in MDMs after SCI contributes to secondary injury. Here, we report that cPLA2 plays an important role in the myelin-induced inflammatory macrophage phenotype in vitro using macrophages derived from cPLA2 knockout bone marrow. Furthermore, to investigate the role of cPLA2 in MDMs after SCI, we generated female bone marrow chimeras using cPLA2 knock-out donors and assessed locomotor recovery using the Basso Mouse Scale (BMS), CatWalk gait analysis system, and horizontal ladder task over six weeks. We also evaluated tissue sparing and intralesional axon density six weeks after injury. cPLA2 KO chimeras did not display altered locomotor recovery or tissue pathology after SCI compared to WT chimera controls. These data suggest that although cPLA2 plays a critical role in myelin-mediated potentiation of proinflammatory macrophage activation in vitro, it may not contribute to secondary injury pathology in vivo after SCI.

References

Gijon M, Leslie C . Regulation of arachidonic acid release and cytosolic phospholipase A2 activation. J Leukoc Biol. 1999; 65(3):330-6. DOI: 10.1002/jlb.65.3.330. View

Scheff S, Rabchevsky A, Fugaccia I, Main J, Lumpp Jr J . Experimental modeling of spinal cord injury: characterization of a force-defined injury device. J Neurotrauma. 2003; 20(2):179-93. DOI: 10.1089/08977150360547099. View

Sarkar C, Jones J, Hegdekar N, Thayer J, Kumar A, Faden A . PLA2G4A/cPLA2-mediated lysosomal membrane damage leads to inhibition of autophagy and neurodegeneration after brain trauma. Autophagy. 2019; 16(3):466-485. PMC: 6999646. DOI: 10.1080/15548627.2019.1628538. View

Bartoli F, Lin H, Ghomashchi F, Gelb M, Jain M, Apitz-Castro R . Tight binding inhibitors of 85-kDa phospholipase A2 but not 14-kDa phospholipase A2 inhibit release of free arachidonate in thrombin-stimulated human platelets. J Biol Chem. 1994; 269(22):15625-30. View

Lopez-Vales R, Ghasemlou N, Redensek A, Kerr B, Barbayianni E, Antonopoulou G . Phospholipase A2 superfamily members play divergent roles after spinal cord injury. FASEB J. 2011; 25(12):4240-52. PMC: 3236632. DOI: 10.1096/fj.11-183186. View

Gensel J, Nakamura S, Guan Z, van Rooijen N, Ankeny D, Popovich P . Macrophages promote axon regeneration with concurrent neurotoxicity. J Neurosci. 2009; 29(12):3956-68. PMC: 2693768. DOI: 10.1523/JNEUROSCI.3992-08.2009. View

Stephenson D, Rash K, Smalstig B, Roberts E, Johnstone E, Sharp J . Cytosolic phospholipase A2 is induced in reactive glia following different forms of neurodegeneration. Glia. 1999; 27(2):110-28. DOI: 10.1002/(sici)1098-1136(199908)27:2<110::aid-glia2>3.0.co;2-c. View

Wang X, Cao K, Sun X, Chen Y, Duan Z, Sun L . Macrophages in spinal cord injury: phenotypic and functional change from exposure to myelin debris. Glia. 2014; 63(4):635-51. PMC: 4331228. DOI: 10.1002/glia.22774. View

Kigerl K, Gensel J, Ankeny D, Alexander J, Donnelly D, Popovich P . Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci. 2009; 29(43):13435-44. PMC: 2788152. DOI: 10.1523/JNEUROSCI.3257-09.2009. View

10.

Kopper T, Zhang B, Bailey W, Bethel K, Gensel J . The effects of myelin on macrophage activation are phenotypic specific via cPLA in the context of spinal cord injury inflammation. Sci Rep. 2021; 11(1):6341. PMC: 7973514. DOI: 10.1038/s41598-021-85863-6. View

11.

Wang S, Li B, Solomon V, Fonteh A, Rapoport S, Bennett D . Calcium-dependent cytosolic phospholipase A activation is implicated in neuroinflammation and oxidative stress associated with ApoE4. Mol Neurodegener. 2022; 17(1):42. PMC: 9202185. DOI: 10.1186/s13024-022-00549-5. View

12.

Marusic S, Leach M, Pelker J, Azoitei M, Uozumi N, Cui J . Cytosolic phospholipase A2 alpha-deficient mice are resistant to experimental autoimmune encephalomyelitis. J Exp Med. 2005; 202(6):841-51. PMC: 2212947. DOI: 10.1084/jem.20050665. View

13.

Kishimoto K, Matsumura K, Kataoka Y, Morii H, Watanabe Y . Localization of cytosolic phospholipase A2 messenger RNA mainly in neurons in the rat brain. Neuroscience. 1999; 92(3):1061-77. DOI: 10.1016/s0306-4522(99)00051-2. View

14.

Ong W, Horrocks L, Farooqui A . Immunocytochemical localization of cPLA2 in rat and monkey spinal cord. J Mol Neurosci. 1999; 12(2):123-30. DOI: 10.1007/BF02736926. View

15.

Riendeau D, Guay J, Weech P, Laliberte F, Yergey J, Li C . Arachidonyl trifluoromethyl ketone, a potent inhibitor of 85-kDa phospholipase A2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets. J Biol Chem. 1994; 269(22):15619-24. View

16.

Bonventre J, Huang Z, Taheri M, OLeary E, Li E, Moskowitz M . Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature. 1997; 390(6660):622-5. DOI: 10.1038/37635. View

17.

Zrzavy T, Schwaiger C, Wimmer I, Berger T, Bauer J, Butovsky O . Acute and non-resolving inflammation associate with oxidative injury after human spinal cord injury. Brain. 2021; 144(1):144-161. PMC: 7880675. DOI: 10.1093/brain/awaa360. View

18.

Street I, Lin H, Laliberte F, Ghomashchi F, Wang Z, Perrier H . Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2. Biochemistry. 1993; 32(23):5935-40. DOI: 10.1021/bi00074a003. View

19.

Zhu Y, Lyapichev K, Lee D, Motti D, Ferraro N, Zhang Y . Macrophage Transcriptional Profile Identifies Lipid Catabolic Pathways That Can Be Therapeutically Targeted after Spinal Cord Injury. J Neurosci. 2017; 37(9):2362-2376. PMC: 5354348. DOI: 10.1523/JNEUROSCI.2751-16.2017. View

20.

Sun G, Geng X, Teng T, Yang B, Appenteng M, Greenlief C . Dynamic Role of Phospholipases A2 in Health and Diseases in the Central Nervous System. Cells. 2021; 10(11). PMC: 8616333. DOI: 10.3390/cells10112963. View